{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T10:38:35Z","timestamp":1792751915753,"version":"4.5.0"},"reference-count":27,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,1,1]]},"abstract":"\n Objectives.<\/jats:title>\n In the era before widespread use of inhaled nitric oxide, to determine the prevalence of persistent pulmonary hypertension (PPHN) in a multicenter cohort, demographic descriptors of the population, treatments used, the outcomes of those treatments, and variation in practice among centers.<\/jats:p>\n <\/jats:sec>\n \n Study Design.<\/jats:title>\n A total of 385 neonates who received \u226550% inspired oxygen and\/or mechanical ventilation and had documented evidence of PPHN (2D echocardiogram or preductal or postductal oxygen difference) were tracked from admission at 12 Level III neonatal intensive care units. Demographics, treatments, and outcomes were documented.<\/jats:p>\n <\/jats:sec>\n \n Results.<\/jats:title>\n The prevalence of PPHN was 1.9 per 1000 live births (based on 71\u2009558 inborns) with a wide variation observed among centers (.43\u20136.82 per 1000 live births). Neonates with PPHN were admitted to the Level III neonatal intensive care units at a mean of 12 hours of age (standard deviation: 19 hours). Wide variations in the use of all treatments studied were found at the centers. Hyperventilation was used in 65% overall but centers ranged from 33% to 92%, and continuous infusion of alkali was used in 75% overall, with a range of 27% to 93% of neonates. Other frequently used treatments included sedation (94%; range: 77%\u2013100%), paralysis (73%; range: 33%\u201398%), and inotrope administration (84%; range: 46%\u2013100%). Vasodilator drugs, primarily tolazoline, were used in 39% (range: 13%\u201381%) of neonates. Despite the wide variation in practice, there was no significant difference in mortality among centers. Mortality was 11% (range: 4%\u201333%). No specific therapy was clearly associated with a reduction in mortality.<\/jats:p>\n To determine whether the therapies were equivalent, neonates treated with hyperventilation were compared with those treated with alkali infusion. Hyperventilation reduced the risk of extracorporeal membrane oxygenation without increasing the use of oxygen at 28 days of age. In contrast, the use of alkali infusion was associated with increased use of extracorporeal membrane oxygenation (odds ratio: 5.03, compared with those treated with hyperventilation) and an increased use of oxygen at 28 days of age.<\/jats:p>\n <\/jats:sec>\n \n Conclusions.<\/jats:title>\n Hyperventilation and alkali infusion are not equivalent in their outcomes in neonates with PPHN. Randomized trials are needed to evaluate the role of these common therapies.<\/jats:p>\n <\/jats:sec>","DOI":"10.1542\/peds.105.1.14","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T23:50:41Z","timestamp":1092441041000},"page":"14-20","source":"Crossref","is-referenced-by-count":476,"title":["Persistent Pulmonary Hypertension of the Newborn in the Era Before Nitric Oxide: Practice Variation and Outcomes"],"prefix":"10.1542","volume":"105","author":[{"given":"Michele C.","family":"Walsh-Sukys","sequence":"first","affiliation":[{"name":"From the Case Western Reserve University, Cleveland, Ohio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon E.","family":"Tyson","sequence":"additional","affiliation":[{"name":"University of Texas Southwestern Medical Center, Dallas, Texas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda L.","family":"Wright","sequence":"additional","affiliation":[{"name":"National Institute of Child Health and Human Development, Bethesda, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles R.","family":"Bauer","sequence":"additional","affiliation":[{"name":"University of Miami, Miami, Florida;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheldon B.","family":"Korones","sequence":"additional","affiliation":[{"name":"University of Tennessee, Memphis, Tennessee;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Stevenson","sequence":"additional","affiliation":[{"name":"Stanford University, Stanford, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Verter","sequence":"additional","affiliation":[{"name":"Biostatistics Center, George Washington University, Washington DC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara J.","family":"Stoll","sequence":"additional","affiliation":[{"name":"Emory University, Atlanta, Georgia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Lemons","sequence":"additional","affiliation":[{"name":"Indiana University, Indianapolis, Indiana;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-Ann","family":"Papile","sequence":"additional","affiliation":[{"name":"University of New Mexico, Albuquerque, New Mexico;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seetha","family":"Shankaran","sequence":"additional","affiliation":[{"name":"Wayne State University, Detroit, Michigan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward F.","family":"Donovan","sequence":"additional","affiliation":[{"name":"University of Cincinnati, Cincinnati, Ohio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Oh","sequence":"additional","affiliation":[{"name":"Women & Infants Hospital, Providence, Rhode Island; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Ehrenkranz","sequence":"additional","affiliation":[{"name":"Yale University, New Haven, Connecticut."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avroy A.","family":"Fanaroff","sequence":"additional","affiliation":[{"name":"From the Case Western Reserve University, Cleveland, Ohio;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2000,1,1]]},"reference":[{"key":"2021121010274890100_B1","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1001\/archpedi.1984.02140440076021","article-title":"Persistent pulmonary hypertension of the newborn: trends in incidence, diagnosis and management.","volume":"138","author":"Heymann","year":"1984","journal-title":"Am J Dis Child"},{"key":"2021121010274890100_B2","first-page":"357","article-title":"Persistent pulmonary hypertension of the newborn treated with hyperventilation: clinical features and outcome.","volume":"24","author":"John","year":"1988","journal-title":"Aust Paediatr J"},{"key":"2021121010274890100_B3","first-page":"37","article-title":"Persistence of the fetal circulation.","volume":"2","author":"Goetzman","year":"1980","journal-title":"Pediatr Res"},{"key":"2021121010274890100_B4","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0022-3476(78)81239-6","article-title":"Physiologic factors affecting pulmonary artery pressures in infants with persistent pulmonary hypertension.","volume":"93","author":"Peckham","year":"1978","journal-title":"J Pediatr"},{"key":"2021121010274890100_B5","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0022-3476(81)80775-5","article-title":"The independent effects of hyperventilation, tolazoline, and dopamine in infants with persistent pulmonary hypertension.","volume":"98","author":"Drummond","year":"1981","journal-title":"J Pediatr"},{"key":"2021121010274890100_B6","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1542\/peds.76.4.488","article-title":"Management of infants with severe respiratory failure and persistence of the fetal circulation without hyperventilation.","volume":"76","author":"Wung","year":"1985","journal-title":"Pediatrics"},{"key":"2021121010274890100_B7","first-page":"303","article-title":"Treatment of PPHN of the newborn without hyperventilation: assessment of the diffusion of an innovation.","volume":"94","author":"Walsh-Sukys","year":"1994","journal-title":"Pediatrics"},{"key":"2021121010274890100_B8","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0022-3476(94)70134-2","article-title":"Severe respiratory failure in neonates: mortality and morbidity rates and neurodevelopmental outcomes.","volume":"125","author":"Walsh-Sukys","year":"1994","journal-title":"J Pediatr"},{"key":"2021121010274890100_B9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0022-3476(96)70439-0","article-title":"Predictors of early childhood outcome in candidates for extracorporeal membrane oxygenation.","volume":"128","author":"Vaucher","year":"1996","journal-title":"J Pediatr"},{"key":"2021121010274890100_B10","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/00007611-199706000-00009","article-title":"Ventilator management of infants before extracorporeal membrane oxygenation.","volume":"90","author":"Edwards","year":"1997","journal-title":"South Med J"},{"key":"2021121010274890100_B11","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0022-3476(84)80563-6","article-title":"Acute cardiopulmonary effects of pancuronium bromide in mechanically ventilated newborn infants.","volume":"104","author":"Runkle","year":"1984","journal-title":"J Pediatr"},{"key":"2021121010274890100_B12","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1056\/NEJM199702273360901","article-title":"Inhaled nitric oxide in full-term and nearly full-term infants with hypoxia respiratory failure.","volume":"336","author":"The Neonatal Inhaled Nitric Oxide Study Group","year":"1997","journal-title":"N Engl J Med"},{"key":"2021121010274890100_B13","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/jama.1987.03390070053022","article-title":"Use of claims data systems to evaluate health outcomes: mortality and reoperation following prostatectomy.","volume":"257","author":"Wennberg","year":"1987","journal-title":"JAMA"},{"key":"2021121010274890100_B14","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1001\/jama.1988.03720200049032","article-title":"An assessment of prostatectomy for benign uninary tract obstruction.","volume":"259","author":"Wennberg","year":"1988","journal-title":"JAMA"},{"key":"2021121010274890100_B15","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jama.1988.03410040077031","article-title":"The appropriatness of performing coronary artery bypass surgery.","volume":"260","author":"Winslow","year":"1989","journal-title":"JAMA"},{"key":"2021121010274890100_B16","first-page":"722","article-title":"The appropriateness of carotid endarterectomy.","volume":"18","author":"Winslow","year":"1988","journal-title":"N Engl J Med"},{"key":"2021121010274890100_B17","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1542\/peds.99.2.149","article-title":"Hospital and patient characteristics associated with variation in 28 day mortality rates for very low birth weight infants.","volume":"99","author":"Horbar","year":"1997","journal-title":"Pediatrics"},{"key":"2021121010274890100_B18","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1542\/peds.101.2.194","article-title":"Variations in transfusion practice in neonatal intensive care.","volume":"101","author":"Ringer","year":"1998","journal-title":"Pediatrics."},{"key":"2021121010274890100_B19","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/archpedi.152.9.844","article-title":"Variation among neonatal intensive care units in narcotic administration.","volume":"152","author":"Kahn","year":"1998","journal-title":"Arch Pediatr Adolesc Med."},{"key":"2021121010274890100_B20","first-page":"395","article-title":"The benchmarking effort for networking children's hospitals.","volume":"21","author":"Porter","year":"1995","journal-title":"J Qual Improv"},{"key":"2021121010274890100_B21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(96)04100-1","article-title":"UK collaborative randomized trial of neonatal extracorporeal membrane oxygenation.","volume":"348","author":"UK Collaborative ECMO Trial Group","year":"1996","journal-title":"Lancet"},{"key":"2021121010274890100_B22","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1749-6632.1993.tb26334.x","article-title":"Regional organization for outcomes research. In: Warren KS, Mosteller F, eds. Doing More Good Than Harm: The Evaluation of Health Care Interventions.","volume":"703","author":"O'Connor","year":"1993","journal-title":"Ann N Y Acad Sci"},{"key":"2021121010274890100_B23","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1001\/jama.1989.03430200113036","article-title":"The case for using industrial management science in health care organizations.","volume":"262","author":"Laffel","year":"1989","journal-title":"JAMA"},{"key":"2021121010274890100_B24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00019514-199402020-00009","article-title":"Using measurement and feedback to reduce health care costs and modify physician practice patterns.","volume":"2","author":"Manus","year":"1994","journal-title":"Qual Manage Health Care"},{"key":"2021121010274890100_B25","first-page":"51","article-title":"How hospitals can use internal benchmark data to create effective managed care arrangements.","volume":"2","author":"Alba","year":"1994","journal-title":"Manage Care Q"},{"key":"2021121010274890100_B26"},{"key":"2021121010274890100_B27","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/jama.1996.03540110043030","article-title":"The effectiveness of right heart catheterization in the initial care of critically ill patients: support investigators.","volume":"276","author":"Conners","year":"1996","journal-title":"JAMA"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/105\/1\/14\/842471\/14.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/105\/1\/14\/842471\/14.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T23:01:05Z","timestamp":1639177265000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/105\/1\/14\/65682\/Persistent-Pulmonary-Hypertension-of-the-Newborn"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1,1]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2000,1,1]]},"published-print":{"date-parts":[[2000,1,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.105.1.14","relation":{},"ISSN":["1098-4275","0031-4005"],"issn-type":[{"value":"1098-4275","type":"electronic"},{"value":"0031-4005","type":"print"}],"subject":[],"published":{"date-parts":[[2000,1,1]]}}}